Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Maricar F. Malinis, MD (she/her/hers)

Associate Professor of Medicine
Vanderbilt University Medical Center, TN, United States

Maricar Malinis, MD, is an Associate Professor of Medicine and the Medical Director of the Transplant Infectious Diseases Program at Vanderbilt University Medical Center as of June 2024.
She obtained her medical degree at the University of the Philippines College of Medicine. She completed her internal medicine residency at Seton Hall Graduate Medical Education. Afterward, she completed fellowship training in geriatric medicine at the University of Michigan, infectious diseases at the University of Louisville, and transplant infectious diseases at the Cleveland Clinic Foundation.
She is an active member of the American Society of Transplantation (AST), the Transplantation Society, and the IDSA. She was the inaugural chair of the AST IDCOP Older Adult Working Group (2019-2021). She served on various IDSA committees, including the Clinical Affairs Committee ( member, 2017-2021), Digital Advisory Group (vice-chair 2020-2021, chair 2021-2023), and IDWeek Program Committee (2019-present). She was appointed chair of the IDSA Immunocompromised Host Community of Practice in 2023.
Her research focuses on clinical outcomes of transplantation in people living with HIV and older adults. She is the primary investigator of the HIV Organ Policy Equity (HOPE) Act clinical trial at Yale and several multi-center clinical trials of novel anti-viral agents for immunocompromised hosts. She has led projects on patient safety and quality improvement of care among transplant candidates and recipients, such as optimizing vaccination uptake in this population.

Disclosure(s): Moderna ( concluded): Advisor/Consultant; Paratek Pharmaceuticals, Inc.: Honoraria

Presentation(s):